We are live on ! Find out more
NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

6 hedge funds and large institutions have $167K invested in NeuBase Therapeutics, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+6
Holders Change %
–
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

NBSE Hedge Fund Activity: Q2 2013 in Review

6 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in NeuBase Therapeutics, Inc. Common Stock (NBSE) for Q2 2013, worth a combined $167K.

Buyers outnumbered sellers: 6 funds opened new NBSE positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.

  • 6 institutional investors held NeuBase Therapeutics, Inc. Common Stock (NBSE) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $167K of NeuBase Therapeutics, Inc. Common Stock stock for Q2 2013.
  • 6 funds opened new NeuBase Therapeutics, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +6 holders.

Based on aggregated 13F filings for Q2 2013.